World's Best Scientists 2026 revealed!
E. William St. Clair

E. William St. Clair

D-Index & Metrics

Immunology

D-Index
69
Citations
29246
World Ranking
2466
National Ranking
1178

Overview

E. William St. Clair is affiliated with Duke University in the United States and has a research focus predominantly within the field of Medicine, with 62 publications attributed to this area. Their work spans multiple specialized subfields, including Genetics, Pulmonary and Respiratory Medicine, Rheumatology, Physiology, and Immunology.

The scholar's primary topics of research include:

  • Vasculitis and related conditions
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Salivary Gland Disorders and Functions
  • Chronic Lymphocytic Leukemia Research
  • Rheumatoid Arthritis Research and Therapies
  • Lymphoma Diagnosis and Treatment
  • Monoclonal and Polyclonal Antibodies Research

The most frequent venues for publication are:

  • Arthritis & Rheumatology
  • Annals of the Rheumatic Diseases
  • Arthritis Care & Research
  • JCI Insight
  • Frontiers in Immunology

E. William St. Clair's recent articles include the following:

  • "CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial" (2024, Nature Medicine)
  • "2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis" (2021, Arthritis Care & Research)
  • "2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis" (2021, Arthritis & Rheumatology)
  • "Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial" (2020, Annals of the Rheumatic Diseases)
  • "Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's" (2020, CHEST Journal)

Their collaborations are regularly with a consistent group of co-authors, including:

  • Carol A. Langford
  • Robert Spiera
  • Philip Seo
  • Ulrich Specks
  • Peter A. Merkel

Best Publications

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Jasvinder A. Singh;Kenneth G. Saag;S. Louis Bridges;Elie A. Akl

  • Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

    John H. Stone;Peter A. Merkel;Robert Spiera;Philip Seo

  • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

    E William St Clair;Désirée M F M van der Heijde;Josef S Smolen;Ravinder N Maini

  • Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells

    Yohei Iwata;Takashi Matsushita;Mayuka Horikawa;David J. DiLillo

  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Liana Fraenkel;Joan M Bathon;Bryant R England;E William St Clair

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis: ACR RA Treatment Recommendations

    Jasvinder A. Singh;Kenneth G. Saag;S. Louis Bridges;Elie A. Akl

  • Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

    Barton F. Haynes;Judith Fleming;E. William St. Clair;Herman Katinger

  • Efficacy of Remission-Induction Regimens for ANCA-associated Vasculitis

    Ulrich Specks;Peter A. Merkel;Philip Seo;Robert Spiera

  • The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial.

    E. William St.Clair;Carrie L. Wagner;Adedigbo A. Fasanmade;Benjamin Wang

  • Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial

    Josef S. Smolen;Désirée M. F. M. Van Der Heijde;E. William St.Clair;Paul Emery

  • A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

    John H. Stone;Gary S. Hoffman;Peter A. Merkel;Yuan I. Min

  • A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial

    Larry W. Moreland;James R. O'Dell;Harold E. Paulus;Jeffrey R. Curtis

  • B-lymphocyte contributions to human autoimmune disease.

    Koichi Yanaba;Jean-David Bouaziz;Takashi Matsushita;Cynthia M. Magro

  • Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review

    Joel M. Kremer;Graciela S. Alarcón;Michael E. Weinblatt;Mari V. Kaymakcian

  • Risk Factors for Methotrexate-Induced Lung Injury in Patients with Rheumatoid Arthritis: A Multicenter, Case-Control Study

    Graciela S. Alarcon;Joel M. Kremer;Maurizio Macaluso;Michael E. Weinblatt

  • CTLA4Ig: bridging the basic immunology with clinical application.

    Jeffrey A. Bluestone;E. William St. Clair;E. William St. Clair;Laurence A. Turka;Laurence A. Turka

  • ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.

    Javier D. Finkielman;Augustine S. Lee;Amber M. Hummel;Margaret A. Viss

  • Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus.

    Glinda S. Cooper;Mary Anne Dooley;Edward L. Treadwell;E. William St. Clair

  • Brief communication: High incidence of venous thrombotic events among patients with Wegener granulomatosis - The Wegener's clinical occurrence of thrombosis (WeCLOT) study

    Peter A. Merkel;Grace H. Lo;Janet T. Holbrook;Andrea K. Tibbs

  • Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial

    Martha L. Barnett;Joel M. Kremer;E. William St. Clair;Daniel O. Clegg

  • A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis

    Nathan Vastesaeger;Stephen Xu;Daniel Aletaha;E. William St Clair

  • Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis

    Javier D. Finkielman;Peter A. Merkel;Darrell Schroeder;Gary S. Hoffman

  • Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type

    Sebastian Unizony;Miguel Villarreal;Eli M Miloslavsky;Na Lu

Frequent Co-Authors

Peter A. Merkel
Peter A. Merkel University of Pennsylvania
John H. Stone
John H. Stone Harvard University
Ulrich Specks
Ulrich Specks Mayo Clinic
Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
David S. Pisetsky
David S. Pisetsky Duke University
Alfred Mahr
Alfred Mahr Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their career within the field of Immunology, pursuing related online degrees can provide valuable opportunities. Many students start with foundational programs such as online BSN programs for non nurses. These programs are designed to help individuals without prior nursing experience enter healthcare, opening doors to specializations including immunology.

As students progress, accelerated pathways such as accelerated RN to NP programs offer a fast-tracked route to becoming a nurse practitioner. This advancement allows for deeper clinical roles related to immune system disorders and treatments.

Specialized certification, like the acute care certification for FNP, is another crucial step for nurse practitioners aiming to work with critical immunological conditions in acute care settings. Certification enhances clinical expertise and marketability.

Career growth is also reflected in compensation, and understanding the doctor of nursing practice salary landscape can help students make informed decisions about their educational investments and career trajectories in immunology-related nursing.

Best Scientists Citing E. William St. Clair

Trending Scientists

Recently Published Articles